| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer
|
Wei, Cynthia X.
|
|
|
24 |
4 |
p. 347-352
|
artikel
|
| 2 |
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2
|
Tsutani, Yasuhiro
|
|
|
24 |
4 |
p. 376-380
|
artikel
|
| 3 |
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy
|
Vihinen, Hannes
|
|
|
24 |
4 |
p. 295-304
|
artikel
|
| 4 |
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS)
|
Miyanaga, Akihiko
|
|
|
24 |
4 |
p. 371-375
|
artikel
|
| 5 |
Association of Reported Candidate Monogenic Genes With Lung Cancer Risk
|
Rifkin, Andrew S.
|
|
|
24 |
4 |
p. 313-321
|
artikel
|
| 6 |
Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing
|
García-Pardo, Miguel
|
|
|
24 |
4 |
p. 366-370
|
artikel
|
| 7 |
Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
|
Meador, Catherine B.
|
|
|
24 |
4 |
p. 353-359
|
artikel
|
| 8 |
Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to Osimertinib
|
Smith, Jarrod T.
|
|
|
24 |
4 |
p. 360-361
|
artikel
|
| 9 |
Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis
|
Izano, Monika A.
|
|
|
24 |
4 |
p. 362-365
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
24 |
4 |
p. A1
|
artikel
|
| 11 |
Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer
|
Osazuwa-Peters, Oyomoare L.
|
|
|
24 |
4 |
p. 305-312
|
artikel
|
| 12 |
Reducing Racial Disparities in the Timeliness of Potential Lung Cancer Evaluation With a Novel Application-Supported Rapid Outpatient Diagnostic Program: An Interrupted Time Series Analysis
|
Kourouni, Ismini
|
|
|
24 |
4 |
p. 339-346
|
artikel
|
| 13 |
Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer
|
Azzoli, Christopher
|
|
|
24 |
4 |
p. 329-338
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
24 |
4 |
p. A3-A5
|
artikel
|
| 15 |
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
|
Prelaj, Arsela
|
|
|
24 |
4 |
p. 381-387
|
artikel
|
| 16 |
Thoracic Radiation in Limited Stage Small Cell Lung Cancer: Trends in Radiation Fractionation
|
Kazemi, Mehdi
|
|
|
24 |
4 |
p. 322-328
|
artikel
|
Tijdschrift beschrijving